Free Trial

Tivic Health Systems Q2 2023 Earnings Report

Tivic Health Systems logo
$0.28 -0.01 (-2.96%)
As of 01/21/2025 04:00 PM Eastern

Tivic Health Systems EPS Results

Actual EPS
-$7.00
Consensus EPS
-$8.00
Beat/Miss
Beat by +$1.00
One Year Ago EPS
N/A

Tivic Health Systems Revenue Results

Actual Revenue
$0.16 million
Expected Revenue
$0.63 million
Beat/Miss
Missed by -$470.00 thousand
YoY Revenue Growth
N/A

Tivic Health Systems Announcement Details

Quarter
Q2 2023
Time
N/A

Conference Call Resources

Tivic Health Systems Earnings Headlines

CEO Letter to Shareholders Issued by Tivic Health
Trump’s Inauguration Shocker: “Move Your Cash Now”
Just in the first week after Trump's win, many stocks jumped by double and even triple digits. But now he's issuing this NEW warning about Trump's inauguration.
Tivic Health Systems Advances in Bioelectronic Medicine
Tivic Health Systems Reports Third Quarter 2024 Results
See More Tivic Health Systems Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Tivic Health Systems? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Tivic Health Systems and other key companies, straight to your email.

About Tivic Health Systems

Tivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors. Tivic Health Systems (NASDAQ:TIVC) was incorporated in 2016 and is headquartered in Hayward, California.

View Tivic Health Systems Profile

More Earnings Resources from MarketBeat